Back to Search
WILLIAM MIDDLESWORTH, M.D.
M.D.
Pediatric Surgery Physician
NPI: 1679666440Individual
Specialties, Licenses & Credentials
Pediatric Surgery PhysicianPrimary
Surgery — Pediatric Surgery
Code: 2086S0120X
207418(NY)
Research & Publications (15)
Thoracoscopic lobectomy for severe bronchiectasis in children.
PMID 19575632·J Laparoendosc Adv Surg Tech A·2009
8-other
Percutaneous distal perfusion of the lower extremity after femoral cannulation for venoarterial extracorporeal membrane oxygenation in a small child.
PMID 19231552·J Pediatr Surg·2009
5-case
Therapeutic plasma exchange performed in parallel with extra corporeal membrane oxygenation for antibody mediated rejection after heart transplantation.
PMID 18080271·J Clin Apher·2007
5-case
Vascular remodeling marks tumors that recur during chronic suppression of angiogenesis.
PMID 14757844·Mol Cancer Res·2004
7-preclinical
Duodenal atresia associated with proximal jejunal perforations: a case report and review of the literature.
PMID 14523829·J Pediatr Surg·2003
5-case
Anti-VEGF antibody in experimental hepatoblastoma: suppression of tumor growth and altered angiogenesis.
PMID 12632340·J Pediatr Surg·2003
7-preclinical
Topotecan is anti-angiogenic in experimental hepatoblastoma.
PMID 12037749·J Pediatr Surg·2002
7-preclinical
Resistance of a VEGF-producing tumor to anti-VEGF antibody: unimpeded growth of human rhabdoid tumor xenografts.
PMID 11877682·J Pediatr Surg·2002
7-preclinical
p53 accumulation in favorable-histology Wilms tumor is associated with angiogenesis and clinically aggressive disease.
PMID 11877681·J Pediatr Surg·2002
7-preclinical
Distinct response of experimental neuroblastoma to combination antiangiogenic strategies.
PMID 11877680·J Pediatr Surg·2002
7-preclinical
Novel use of an established agent: Topotecan is anti-angiogenic in experimental Wilms tumor.
PMID 11733906·J Pediatr Surg·2001
7-preclinical
Combination antiangiogenic therapy: increased efficacy in a murine model of Wilms tumor.
PMID 11479851·J Pediatr Surg·2001
4-observational
Highly specific antiangiogenic therapy is effective in suppressing growth of experimental Wilms tumors.
PMID 11172434·J Pediatr Surg·2001
7-preclinical
All angiogenesis is not the same: Distinct patterns of response to antiangiogenic therapy in experimental neuroblastoma and Wilms tumor.
PMID 11172417·J Pediatr Surg·2001
7-preclinical
Trisomy 1q, 2, and 20 in a case of hepatoblastoma: possible significance of 2q35-q37 and 1q12-q21 rearrangements.
PMID 11150606·Cancer Genet Cytogenet·2000
5-case
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3959 BROADWAY, RM 216N
NEW YORK, NY 10032 - Phone
- (212) 342-8585
Quick Facts
- NPI
- 1679666440
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 15
Are you this provider?
Claim Your Profile